New surgical implant tested for stubborn glaucoma

NCT ID NCT05557058

Summary

This early study is testing a new surgical implant designed to help control eye pressure in people with a common type of glaucoma when eye drop medications are not enough. It is specifically for patients where standard glaucoma surgery is more likely to fail because of scarring. The study will enroll about 30 adults to see if the implant is safe and can effectively lower eye pressure for at least six months.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY OPEN ANGLE GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Laser Center

    Santo Domingo, Dominican Republic

Conditions

Explore the condition pages connected to this study.